Advanced search
Publication Cover
Pathology Volume 31, 1999 - Issue 3
Submit an article Journal homepage
9
Views
2
CrossRef citations to date
0
Altmetric
Research Article

MUTATIONS IN rpoB GENE AND RIFABUTIN SUSCEPTIBILITY OF MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED IN AUSTRALIA

VITALI SINTCHENKO, WILLIAM K. CHEW, PETER J. JELFS, GWENDOLYN L. GILBERT Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia
Pages 257-260 | Published online: 06 Jul 2009

  • Weltman AC, Righi SP, DiFerdinando GT, et al Rifampicin-resistant Mycobacterium tuberculosis. Lancet 1995; 345: 1513.
  • Sepkowitz KA, Raffalli J, Riley L, et al. Tuberculosis in the AIDS era. Clin Microbiol Rev 1995; 8(2): 180-99.
  • Gilbert GL. Multidrug-resistant tuberculosis: prevention is better than cure. Med J Aust 1996; 164: 121-4.
  • Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8: 496-514.
  • Dawson D. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1996. Commun Dis Intell 1998; 22: 183-8.
  • Munsiff SS, Joseph S, Ebrahimzadeh A, Frieden TR. Rifampinmonoresistant tuberculosis in New York City, 1993-1994. Clin Infect Dis 1997; 25: 1465-7.
  • Dawson DJ, Cheah DF, Chew WK, et al. Tuberculosis in Australia, 1989-1992. Bacteriologically confirmed cases and drug resistance. Med J Aust 1995; 162: 287-90.
  • Williams DL, Waguespack C, Eisenach K, et al. Characterization of rifampicin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994; 38: 2380-6.
  • Kunin CM. Antimicrobial activity of rifabutin. Clin Infect Dis 1996; 22 (Suppl 1): 3-14.
  • Telenti A, Imboden P, Marches! F, et al. Detection of rifampicinresistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341:647-50.
  • Miller LP, Crawford JT, Shinnick TM. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994; 38: 805-11.
  • Morris S, Bai GH, Suffys P, et al. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 1995; 171:954-60.
  • Zhang Y, Young D. Molecular genetics of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 1994; 34: 313-9.
  • FeImlee TA, Liu Q, Whelen AC, et al. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol 1995; 33: 1617-23.
  • Kapur V, Li L-L, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase â-subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994; 32: 1095-8.
  • Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis 1995; 76: 425-30.
  • Cooksey RC, M or lock GP, Glickman S, Crawford JT. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampinresistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997; 35: 1281-3.
  • Rossau R, Traore H, Beenhouwer H, et al. Evaluation of the INNOLiPA Rif.TB Assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997; 41: 2093-8.
  • Drobniewski FA, Wilson SM. The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a molecular story. / Med Microbiol 1998; 47: 189-96.
  • Matsiota-Bernard P, Vrioni G, Marinis E. Characterization of rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998; 36: 20-3.
  • Kim B-J, Kim S-Y, Park B-H, et al. Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. / Clin Microbiol 1997; 35: 492-4.
  • Ohno H, Koga H, Kohno S, et al. Relationship between rifampin MICs and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother 1996; 40: 1053-6.
  • Bishai WR, Graham NMH, Harrington S, et al. Brief report: Rifampicin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. New Engl J Med 1996; 334: 1573-6.
  • Bodmer T, Zurcher G, Imboden P, Telenti A. Mutation position and type of substitution in the â-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J Antimicrob Chemother 1995; 35: 345-8.
  • Bifani PJ, Plikay BB, Kapur V, et al. Origin and interstate spread of a New York City muhidrug-resistant Mycobacterium tuberculosis clone family. / Am Med Assoc 1996; 275: 452-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.